# | Side effect | Count |
---|---|---|
0 | PSORIASIS | 288 |
1 | DRUG INEFFECTIVE | 167 |
2 | ARTHRALGIA | 134 |
3 | FATIGUE | 106 |
4 | PSORIATIC ARTHROPATHY | 96 |
5 | HEADACHE | 86 |
6 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 79 |
7 | THERAPY INTERRUPTED | 78 |
8 | INTENTIONAL PRODUCT USE ISSUE | 75 |
9 | PRODUCT DOSE OMISSION ISSUE | 75 |
# | Side effect | Count | Frequency |
---|---|---|---|
0 | VACCINATION SITE DISCHARGE | 4 | 0.8000 |
1 | ANTITHROMBIN III ABNORMAL | 1 | 0.5000 |
2 | LICHENOID DYSPLASIA | 1 | 0.5000 |
3 | ACROKERATOSIS PARANEOPLASTICA | 4 | 0.5000 |
4 | VACCINATION SITE VESICLES | 4 | 0.2500 |
5 | MATERNAL EXPOSURE VIA PARTNER DURING PREGNANCY | 2 | 0.1429 |
6 | VACCINATION SITE HAEMORRHAGE | 4 | 0.1333 |
7 | COLLAGEN-VASCULAR DISEASE | 8 | 0.1212 |
8 | MUCOCUTANEOUS CANDIDIASIS | 7 | 0.1000 |
9 | PYODERMA STREPTOCOCCAL | 2 | 0.0952 |